Becton, Dickinson and Co. | BDX - Ebit

Precio De Mercado
152.13
Cambio Diario
-2.72 -1.76%
Mensual
-3.88%
Anual
-25.82%
Q2 Expectativa
155.05




Ebit Cambio Fecha
Abbott USD 1.85B 684M 2026-03
Agilent USD 353M 90M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
AngioDynamics USD -2.51M 5.41M 2025-09
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio-Rad Laboratories USD -418.8M 845.4M 2025-09
Boston Scientific USD 1.24B 203M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 538M 26M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Globus Medical USD 181.31M 298.83M 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.51B 2026-03
Masimo USD 83.9M 200K 2025-12
Medtronic USD 1.74B 40M 2025-12
Solventum Corp USD 105M 1.58B 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 76.31M 2025-12
Terumo JPY 43.88B 1.21B 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12